[Analysis of national leprosy surveillance data in Mauritania from 2009 to 2019].
Autor: | Boushab BM; Médecine interne et maladies infectieuses, Centre hospitalier de Kiffa, Assaba, Mauritanie.; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso., Yanogo PK; Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso., Barry D; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso., Maham MH; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Direction générale des Services de santé des Forces armées et de sécurité, Nouakchott, Mauritanie., Traoré AMK; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie., Kane EM; Programme national de lutte contre la tuberculose et la lèpre (PNTL), Nouakchott, Mauritanie., Basco L; Aix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.; IHU-Méditerranée Infection, Marseille, France., Meda N; Faculté de médecine, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.; Épidémiologie de terrain et de laboratoire du Burkina Faso, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso. |
---|---|
Jazyk: | francouzština |
Zdroj: | Medecine tropicale et sante internationale [Med Trop Sante Int] 2023 Apr 20; Vol. 3 (2). Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023). |
DOI: | 10.48327/mtsi.v3i2.2023.361 |
Abstrakt: | Introduction: Leprosy is a chronic infectious disease that mainly affects the skin, mucous membranes and the peripheral nervous system. Its elimination as a public health problem seems to lead to its ignorance and therefore to a risk of late diagnosis. An analysis of leprosy surveillance data in Mauritania was conducted to determine epidemiological trends and clinical forms of reported cases. Material and Method: The retrospective study was based on the epidemiological records of leprosy in Mauritania from 2009 to 2019. The diagnosis of leprosy was made on the basis of the diagnostic criteria of the World Health Organization (WHO). Data were analyzed using Epi Info version 7.2.5.0. The frequencies, proportions, and rates were calculated. Results: Over the past 11 years, 164 cases have been notified. Among the notified cases, 96/164 (58.5%) were males and 68/164 (41.5%) females, with a sex ratio of 1.4. The mean age (± standard deviation) was 44.0 ± 17.1 years [range, 9 - 86 years], and the median was 45 years [interquartile range, 32.5; 57.5]. Children under the age of 16 accounted for 9/164 (5.5%). The wilayas (i.e. "regions") of Nouakchott were the most endemic regions in the country. The multibacillary form (MB) represented 109/164 (66.5%) cases among the observed clinical forms. The average annual incidence was 0.3 case/100,000 population for MB and 0.1 case/100,000 for PB (paucibacillary). All reported cases were treated with multidrug therapy. Conclusion: The results of leprosy surveillance showed a persistence of this disease in Mauritania. It is necessary to relaunch leprosy services at all levels in order to continue to reduce the morbidity associated with this disease, and eventually eliminate it from the country. (Copyright © 2023 SFMTSI.) |
Databáze: | MEDLINE |
Externí odkaz: |